Trio Clinical Resourcing Joins Forces with DOCS

As we continue to expand our services to provide strategic resourcing solutions that are flexible and tailored to meet our customer resourcing needs, DOCS is constantly looking for ways to grow our business and increase global coverage.

I am therefore very pleased to announce that Trio Clinical Resourcing will become a fully integrated part of the DOCS business, as a result of ICON’s recent acquisition of Aptiv Solutions. This acquisition supports our ongoing plan to expand our global coverage, particularly in the US. Trio, a well-established resourcing provider, complements our existing business and aligns with our commitment to deliver excellence in insourcing and outsourcing services.

Trio was founded in 2002 to meet the growing need for talent within the clinical trials industry. They have collaborated on more than 1,000 clinical trials across nearly every therapeutic area for a wide variety of customers including large pharmaceutical, small biotechnology, medical device, and in vitro diagnostics companies. In addition to servicing customers throughout North America, Europe, Latin America, Australia, and the Middle East, Trio boast a candidate network that is geographically rich and therapeutically diverse.

With this integration, Trio brings a strong team of operational and therapeutic experts with in-depth understanding of resourcing needs in drug development. Further, Trio’s core competency of resourcing top talent, identifying, evaluating, and securing experienced professionals across multiple disciplines in clinical research supports DOCS’ goal to give our customers immediate access to proven resources to meet their project team needs.

We are excited to welcome Trio to our organisation. Together, DOCS and Trio will lead the way in strategically resourcing the most effective and efficient clinical resourcing solutions.